Mouse strain differences in phencyclidine-induced behavioural changes.
Akihiro Mouri, Takenao Koseki, Shiho Narusawa, Minae Niwa, Takayoshi Mamiya, Shin-Ichi Kano, Akira Sawa, Toshitaka Nabeshima
The International Journal of Neuropsychopharmacology July 1, 2012 DOI: 10.1017/s146114571100085x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Male mice of four strains: C57BL/6N, C57BL/6J, ddY, ICR |
| Key findings | Strain differences were observed in PCP-induced hyperlocomotion and enhanced immobility in the forced swim test (ddY>>C57BL/6N and 6J>ICR), but no strain difference was found in impairment of recognition memory after withdrawal of chronic PCP administration. |
Abstract
Administration of phencyclidine (PCP) is acknowledged to generate a model of psychosis in animals. With the identification of genetic susceptibility factors for schizophrenia and bipolar disorder, great efforts have been made to generate genetic animal models for major mental illnesses. As these disorders are multifactorial, comparisons among drug-induced (non-genetic) and genetic models are becoming an important issue in biological psychiatry. A major barrier is that the standard mouse strain used in the generation of genetic models is C57BL/6, whereas almost all studies with PCP-induced models have utilized other strains. To fill this technical gap, we systematically compared the behavioural changes upon PCP administration in different mouse strains, including C57BL/6N, C57BL/6J, ddY, and ICR. We observed strain differences in PCP-induced hyperlocomotion and enhanced immobility in the forced swim test (ddY>>C57BL/6N and 6J>ICR). In contrast, there was no strain difference in the impairment of recognition memory in the novel object recognition memory test after withdrawal of chronic PCP administration. This study provides practical guidance for comparing genetic with PCP-induced models of psychosis in C57BL/6. Furthermore, such strain differences may provide a clue to the biological mechanisms underlying PCP-induced endophenotypes possibly relevant to major mental illnesses.
Citations in the library
Cited by 9
- Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions International Journal of Molecular Sciences October 26, 2020
- Biological variations in ketamine sensitivity: insights from hyperlocomotion to psychotomimetic features in genetically diverse mouse strains. Psychiatry Research April 1, 2026
- Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and rescue by risperidone bioRxiv January 18, 2023
- Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and partial rescue by risperidone. Frontiers in Cellular Neuroscience 2023
- Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice. European Neuropsychopharmacology December 2020
and 4 more in the library
Cites 12
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Science August 19, 2010
- Study of a New Schizophrenomimetic Drug—Sernyl Archives of Neurology And Psychiatry March 1, 1959
- Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. European Journal of Pharmacology March 3, 1987
- Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice. The International Journal of Neuropsychopharmacology March 2009
and 7 more in the library